Improving the approach to and management of the older patient with metastatic gastric cancer (Fox Chase MGC)

General Information Age Group Adults ages 40 and older Status Recruiting Protocol Number NCT04618809 Background Information The purpose of this research study is to enhance the care of the older patient with mGC/mEC/mGEJC. The study will evaluate the benefit of incorporating geriatric assessments into the routine care of patients. Offered At Inova Schar Cancer Institute 8081 Innovation Park Drive Fairfax, VA 22031A department of Inova Fairfax Hospital Eligibility Information Adults age 70 and older Ability to read and understand English, ability to sign consent, and complete a self-assessment evaluation Evidence of metastatic gastric cancer (mGC), metastatic esophageal cancer (mEC), or metastatic gastroesophageal junction cancer (mGEJC). Patients can be enrolled at any stage of their treatment or disease course Ongoing active therapy for mGC. Patients can be treated with any type of therapy including chemotherapy, immunotherapy or Her-2 targeted therapy Life expectancy ≥3 months Additional eligibility in protocol Ineligibility Information ≤69 years old (participants may be eligible at a later date) Inability to read and understand English No evidence of mGC (participants may be eligible if evidence of mGC occurs) Not on active therapy Life expectancy <3 months Additional ineligibility in protocol Additional information can be found at: https://clinicaltrials.gov/ct2/show/NCT04618809 Contact Information Contact Name Mahwish Bari Contact Phone 571-472-1796 Contact Email Send Email